Pulmonx Long Term Debt 2019-2025 | LUNG

Pulmonx long term debt from 2019 to 2025. Long term debt can be defined as the sum of all long term debt fields.
Pulmonx Annual Long Term Debt
(Millions of US $)
2024 $34
2023 $35
2022 $17
2021 $17
2020 $17
2019 $15
2018 $34
Pulmonx Quarterly Long Term Debt
(Millions of US $)
2025-03-31 $29
2024-12-31 $34
2024-09-30 $37
2024-06-30 $37
2024-03-31 $32
2023-12-31 $35
2023-09-30 $37
2023-06-30 $37
2023-03-31 $37
2022-12-31 $17
2022-09-30 $12
2022-06-30 $14
2022-03-31 $17
2021-12-31 $17
2021-09-30 $14
2021-06-30 $15
2021-03-31 $16
2020-12-31 $17
2020-09-30 $47
2020-06-30
2020-03-31
2019-12-31
2019-09-30
2018-12-31 $34
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.129B $0.084B
Pulmonx Corporation is a medical technology company. It designs, develops, manufactures and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. Pulmonx Corporation is based in Redwood City, California.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $45.399B 58.01
Hims & Hers Health (HIMS) United States $11.729B 121.86
Tempus AI (TEM) United States $9.423B 0.00
IRhythm Technologies (IRTC) United States $4.541B 0.00
Inspire Medical Systems (INSP) United States $4.078B 63.71
Privia Health (PRVA) United States $2.749B 187.92
Enovis (ENOV) United States $1.831B 10.21
Clover Health Investments (CLOV) United States $1.593B 0.00
Schrodinger (SDGR) United States $1.573B 0.00
Phreesia (PHR) United States $1.454B 0.00
Omnicell (OMCL) United States $1.397B 24.65
Azenta (AZTA) United States $1.251B 58.15
10x Genomics (TXG) United States $1.149B 0.00
Fulgent Genetics (FLGT) United States $0.627B 0.00
Butterfly Network (BFLY) United States $0.601B 0.00
Claritev (CTEV) United States $0.591B 0.00
Talkspace (TALK) United States $0.549B 164.00
Veradigm (MDRX) United States $0.455B 0.00
Standard BioTools (LAB) United States $0.403B 0.00
TruBridge (TBRG) United States $0.358B 793.67
Outset Medical (OM) United States $0.312B 0.00
Nyxoah SA (NYXH) Belgium $0.266B 0.00
Health Catalyst (HCAT) United States $0.260B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.191B 0.00
KORU Medical Systems (KRMD) United States $0.132B 0.00
EUDA Health Holdings (EUDA) Singapore $0.128B 0.00
American Well (AMWL) United States $0.108B 0.00
MDxHealth SA (MDXH) Belgium $0.102B 0.00
CareCloud (CCLD) United States $0.090B 3.42
111 (YI) China $0.071B 0.00
HeartBeam (BEAT) United States $0.052B 0.00
P3 Health Partners (PIII) United States $0.052B 0.00
Zepp Health (ZEPP) Netherlands $0.036B 0.00
Zhongchao (ZCMD) China $0.028B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.026B 0.00
Streamline Health Solutions (STRM) United States $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
Precipio (PRPO) United States $0.015B 0.00
MSP Recovery (MSPR) United States $0.011B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Movano (MOVE) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.003B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00